Here, we identify ALOX5 as a previously unrecognized direct target of celastrol and further demonstrate that the ALOX5–macrophage axis drives bone destruction in rheumatoid arthritis through a novel transcriptional mechanism involving NF-κB/RELA. This evidence concerns the gene ALOX5 and rheumatoid arthritis.